As senior vice president, finance, Tom Kotarakos leads FogPharma’s finance organization and is responsible for financial planning and analysis and accounting, in addition to thought leadership in financial strategy, capital markets and business development.
Most recently, Tom was the senior vice president of finance and business operations at Codiak BioSciences, where he oversaw the finance, accounting, IT and facilities functions. While at Codiak, he helped drive the S-1, banking and legal processes tied to IPO filing, while leading the transformation of the accounting and finance organization to a public-company posture. Prior to this, Tom held various roles at Seres Therapeutics, where he guided the accounting and finance functions through an IPO and implemented the processes and controls necessary to operate as a public company, with ownership of the accounting and treasury functions. Before his time at Seres, Tom held various management positions at GT Advance Technologies and spent seven years focused on the life sciences industry at PricewaterhouseCoopers.
Tom is a CPA and received his M.S. and B.S. in accounting from Bentley University.